Share Price and Basic Stock Data
Last Updated: March 3, 2026, 2:26 pm
| PEG Ratio | 0.00 |
|---|
📊 Last updated
8d ago
Feb 26, 2026
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Hindustan Organic Chemicals Ltd (HOCL), operating in the organic chemicals sector, reported a price of ₹30.8 and a market capitalization of ₹207 Cr. The company has experienced fluctuating sales figures over the recent quarters, with revenues standing at ₹631 Cr for the year ending March 2023, up from ₹434 Cr the previous year. The trailing twelve months (TTM) sales amounted to ₹592 Cr, indicating a slight decline compared to the fiscal year 2025’s reported sales of ₹536 Cr. Quarterly sales peaked at ₹194 Cr in March 2023 but showed volatility, dropping to ₹145 Cr in June 2023, before rebounding to ₹189 Cr in September 2023. This inconsistency may signal operational challenges or market dynamics affecting demand. The company’s reserves, reported at ₹953 Cr, provide a cushion for operational activities, although the overall sales trajectory suggests a need for strategic focus to stabilize and grow revenue streams.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Hindustan Organic Chemicals Ltd | 198 Cr. | 29.5 | 45.0/22.6 | 152 | 0.00 % | 5.20 % | 21.6 % | 10.0 | |
| Vinati Organics Ltd | 14,252 Cr. | 1,375 | 2,040/1,356 | 29.8 | 287 | 0.55 % | 20.6 % | 15.8 % | 1.00 |
| Seya Industries Ltd | 26.9 Cr. | 10.1 | 24.2/10.1 | 309 | 0.00 % | 0.51 % | 0.77 % | 10.0 | |
| Industry Average | 7,225.00 Cr | 471.53 | 29.80 | 249.33 | 0.18% | 8.77% | 12.72% | 7.00 |
Quarterly Result
| Metric | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 173.84 | 193.84 | 145.46 | 188.73 | 186.82 | 182.87 | 59.36 | 174.72 | 165.16 | 136.62 | 163.89 | 126.27 | 147.24 |
| Expenses | 172.90 | 177.40 | 154.42 | 177.26 | 189.97 | 183.42 | 82.88 | 174.67 | 191.07 | 173.37 | 177.31 | 143.45 | 150.87 |
| Operating Profit | 0.94 | 16.44 | -8.96 | 11.47 | -3.15 | -0.55 | -23.52 | 0.05 | -25.91 | -36.75 | -13.42 | -17.18 | -3.63 |
| OPM % | 0.54% | 8.48% | -6.16% | 6.08% | -1.69% | -0.30% | -39.62% | 0.03% | -15.69% | -26.90% | -8.19% | -13.61% | -2.47% |
| Other Income | 2.62 | -4.67 | 3.21 | 4.70 | 3.53 | 6.68 | 4.64 | 5.05 | -34.53 | 550.76 | 12.62 | 4.75 | 5.40 |
| Interest | 16.95 | 17.11 | 16.97 | 17.45 | 17.68 | 17.48 | 16.05 | 18.15 | 18.26 | -9.60 | 4.98 | 5.26 | 5.13 |
| Depreciation | 0.30 | 0.30 | 0.31 | 0.36 | 0.37 | 0.39 | 0.38 | 0.45 | 0.46 | 0.35 | 0.44 | 0.48 | 0.52 |
| Profit before tax | -13.69 | -5.64 | -23.03 | -1.64 | -17.67 | -11.74 | -35.31 | -13.50 | -79.16 | 523.26 | -6.22 | -18.17 | -3.88 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.64% | 0.00% | 0.00% | 0.00% |
| Net Profit | -13.69 | -5.64 | -23.04 | -1.65 | -17.67 | -11.74 | -35.31 | -13.51 | -79.16 | 519.93 | -6.22 | -18.16 | -3.88 |
| EPS in Rs | -2.01 | -0.63 | -3.44 | -0.21 | -2.65 | -1.77 | -5.27 | -2.03 | -11.76 | 77.39 | -0.94 | -2.70 | -0.58 |
Last Updated: March 3, 2026, 9:12 am
Below is a detailed analysis of the quarterly data for Hindustan Organic Chemicals Ltd based on the most recent figures (Dec 2025) and their trends compared to the previous period:
- For Sales, as of Dec 2025, the value is 147.24 Cr.. The value appears strong and on an upward trend. It has increased from 126.27 Cr. (Sep 2025) to 147.24 Cr., marking an increase of 20.97 Cr..
- For Expenses, as of Dec 2025, the value is 150.87 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 143.45 Cr. (Sep 2025) to 150.87 Cr., marking an increase of 7.42 Cr..
- For Operating Profit, as of Dec 2025, the value is -3.63 Cr.. The value appears strong and on an upward trend. It has increased from -17.18 Cr. (Sep 2025) to -3.63 Cr., marking an increase of 13.55 Cr..
- For OPM %, as of Dec 2025, the value is -2.47%. The value appears strong and on an upward trend. It has increased from -13.61% (Sep 2025) to -2.47%, marking an increase of 11.14%.
- For Other Income, as of Dec 2025, the value is 5.40 Cr.. The value appears strong and on an upward trend. It has increased from 4.75 Cr. (Sep 2025) to 5.40 Cr., marking an increase of 0.65 Cr..
- For Interest, as of Dec 2025, the value is 5.13 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 5.26 Cr. (Sep 2025) to 5.13 Cr., marking a decrease of 0.13 Cr..
- For Depreciation, as of Dec 2025, the value is 0.52 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.48 Cr. (Sep 2025) to 0.52 Cr., marking an increase of 0.04 Cr..
- For Profit before tax, as of Dec 2025, the value is -3.88 Cr.. The value appears strong and on an upward trend. It has increased from -18.17 Cr. (Sep 2025) to -3.88 Cr., marking an increase of 14.29 Cr..
- For Tax %, as of Dec 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 0.00%.
- For Net Profit, as of Dec 2025, the value is -3.88 Cr.. The value appears strong and on an upward trend. It has increased from -18.16 Cr. (Sep 2025) to -3.88 Cr., marking an increase of 14.28 Cr..
- For EPS in Rs, as of Dec 2025, the value is -0.58. The value appears strong and on an upward trend. It has increased from -2.70 (Sep 2025) to -0.58, marking an increase of 2.12.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: February 27, 2026, 7:15 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 236 | 178 | 143 | 176 | 275 | 503 | 325 | 407 | 434 | 631 | 704 | 536 | 574 |
| Expenses | 382 | 306 | 265 | 335 | 442 | 475 | 384 | 381 | 433 | 625 | 705 | 622 | 645 |
| Operating Profit | -146 | -129 | -121 | -159 | -167 | 28 | -58 | 27 | 1 | 6 | -1 | -86 | -71 |
| OPM % | -62% | -72% | -85% | -90% | -61% | 6% | -18% | 7% | 0% | 1% | -0% | -16% | -12% |
| Other Income | 6 | -26 | 15 | 6 | 63 | 117 | 21 | 21 | 34 | 6 | 18 | 526 | 574 |
| Interest | 43 | 53 | 69 | 98 | 78 | 68 | 58 | 54 | 66 | 67 | 70 | 43 | 6 |
| Depreciation | 19 | 10 | 10 | 9 | 6 | 3 | 3 | 3 | 1 | 1 | 1 | 2 | 2 |
| Profit before tax | -202 | -217 | -185 | -259 | -187 | 73 | -98 | -8 | -32 | -55 | -54 | 395 | 495 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 1% | |
| Net Profit | -202 | -217 | -185 | -259 | -187 | 73 | -98 | -8 | -32 | -55 | -54 | 392 | 492 |
| EPS in Rs | -28.41 | -32.07 | -26.82 | -38.37 | -27.79 | 10.79 | -14.33 | 0.38 | -4.41 | -7.95 | -8.13 | 58.32 | 73.17 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -7.43% | 14.75% | -40.00% | 27.80% | 139.04% | -234.25% | 91.84% | -300.00% | -71.88% | 1.82% | 825.93% |
| Change in YoY Net Profit Growth (%) | 0.00% | 22.17% | -54.75% | 67.80% | 111.24% | -373.28% | 326.08% | -391.84% | 228.12% | 73.69% | 824.11% |
Hindustan Organic Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
No data available for the compounded sales growth chart.
Balance Sheet
Last Updated: December 4, 2025, 3:03 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 67 | 67 | 67 | 67 | 67 | 67 | 67 | 67 | 67 | 67 | 67 | 67 | 67 |
| Reserves | -707 | -933 | -1,121 | 52 | -33 | 44 | -50 | -36 | -72 | -118 | -119 | 978 | 953 |
| Borrowings | 556 | 698 | 703 | 603 | 609 | 606 | 521 | 518 | 1,226 | 1,286 | 1,362 | 219 | 232 |
| Other Liabilities | 412 | 459 | 584 | 1,103 | 1,018 | 837 | 841 | 895 | 258 | 242 | 264 | 304 | 286 |
| Total Liabilities | 329 | 292 | 234 | 1,825 | 1,662 | 1,555 | 1,379 | 1,444 | 1,479 | 1,478 | 1,575 | 1,568 | 1,539 |
| Fixed Assets | 151 | 137 | 125 | 1,689 | 154 | 170 | 174 | 136 | 155 | 165 | 226 | 227 | 230 |
| CWIP | 38 | 11 | 4 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 1 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 140 | 143 | 104 | 131 | 1,508 | 1,384 | 1,204 | 1,309 | 1,324 | 1,313 | 1,349 | 1,336 | 1,308 |
| Total Assets | 329 | 292 | 234 | 1,825 | 1,662 | 1,555 | 1,379 | 1,444 | 1,479 | 1,478 | 1,575 | 1,568 | 1,539 |
Below is a detailed analysis of the balance sheet data for Hindustan Organic Chemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 67.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 67.00 Cr..
- For Reserves, as of Sep 2025, the value is 953.00 Cr.. The value appears to be declining and may need further review. It has decreased from 978.00 Cr. (Mar 2025) to 953.00 Cr., marking a decrease of 25.00 Cr..
- For Borrowings, as of Sep 2025, the value is 232.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 219.00 Cr. (Mar 2025) to 232.00 Cr., marking an increase of 13.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 286.00 Cr.. The value appears to be improving (decreasing). It has decreased from 304.00 Cr. (Mar 2025) to 286.00 Cr., marking a decrease of 18.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 1,539.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,568.00 Cr. (Mar 2025) to 1,539.00 Cr., marking a decrease of 29.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 230.00 Cr.. The value appears strong and on an upward trend. It has increased from 227.00 Cr. (Mar 2025) to 230.00 Cr., marking an increase of 3.00 Cr..
- For CWIP, as of Sep 2025, the value is 1.00 Cr.. The value appears to be declining and may need further review. It has decreased from 4.00 Cr. (Mar 2025) to 1.00 Cr., marking a decrease of 3.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 1,308.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,336.00 Cr. (Mar 2025) to 1,308.00 Cr., marking a decrease of 28.00 Cr..
- For Total Assets, as of Sep 2025, the value is 1,539.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,568.00 Cr. (Mar 2025) to 1,539.00 Cr., marking a decrease of 29.00 Cr..
Notably, the Reserves (953.00 Cr.) exceed the Borrowings (232.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -702.00 | -827.00 | -824.00 | -762.00 | -776.00 | -578.00 | -579.00 | -491.00 | 0.00 | 5.00 | -2.00 | -305.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 18 | 51 | 22 | 19 | 11 | 17 | 14 | 3 | 7 | 11 | 10 | 15 |
| Inventory Days | 150 | 208 | 230 | 319 | 176 | 74 | 95 | 103 | 111 | 44 | 53 | 52 |
| Days Payable | 317 | 406 | 733 | 941 | 477 | 133 | 66 | 30 | 58 | 34 | 50 | 42 |
| Cash Conversion Cycle | -149 | -146 | -481 | -604 | -291 | -43 | 43 | 76 | 60 | 21 | 13 | 24 |
| Working Capital Days | -534 | -744 | -1,311 | -2,729 | 330 | 235 | 79 | -15 | -134 | -159 | -199 | 483 |
| ROCE % | -91% | -17% | 16% | -7% | 9% | 4% | 1% | 1% | -5% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 58.33 | -8.05 | -8.24 | -4.37 | -1.31 |
| Diluted EPS (Rs.) | 58.33 | -8.05 | -8.24 | -4.37 | -1.31 |
| Cash EPS (Rs.) | 58.51 | -7.83 | -8.05 | -4.19 | -0.87 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 155.40 | -13.00 | -12.77 | -5.38 | -0.10 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 155.40 | -13.00 | -12.77 | -5.38 | -0.10 |
| Revenue From Operations / Share (Rs.) | 79.66 | 104.64 | 93.87 | 64.47 | 61.70 |
| PBDIT / Share (Rs.) | -9.42 | 2.33 | 1.90 | 3.45 | 7.10 |
| PBIT / Share (Rs.) | -9.67 | 2.12 | 1.72 | 3.28 | 6.67 |
| PBT / Share (Rs.) | 58.70 | -8.22 | -8.23 | -4.37 | -1.30 |
| Net Profit / Share (Rs.) | 58.27 | -8.04 | -8.23 | -4.37 | -1.30 |
| NP After MI And SOA / Share (Rs.) | 58.24 | -8.12 | -7.89 | -3.97 | -1.61 |
| PBDIT Margin (%) | -11.82 | 2.22 | 2.02 | 5.35 | 11.50 |
| PBIT Margin (%) | -12.13 | 2.02 | 1.83 | 5.08 | 10.80 |
| PBT Margin (%) | 73.68 | -7.85 | -8.76 | -6.77 | -2.11 |
| Net Profit Margin (%) | 73.14 | -7.68 | -8.76 | -6.77 | -2.11 |
| NP After MI And SOA Margin (%) | 73.11 | -7.76 | -8.41 | -6.15 | -2.60 |
| Return on Networth / Equity (%) | 37.47 | 0.00 | 0.00 | 0.00 | -34.97 |
| Return on Capital Employeed (%) | -5.43 | 14.22 | 11.03 | 13.99 | 16.73 |
| Return On Assets (%) | 25.04 | -3.47 | -3.56 | -1.81 | -0.75 |
| Long Term Debt / Equity (X) | 0.00 | -0.04 | 0.00 | 0.00 | 2.49 |
| Total Debt / Equity (X) | 0.19 | -16.20 | -16.51 | -197.52 | 13.60 |
| Asset Turnover Ratio (%) | 0.34 | 0.45 | 0.42 | 0.29 | 0.29 |
| Current Ratio (X) | 3.61 | 0.91 | 0.95 | 0.99 | 1.11 |
| Quick Ratio (X) | 3.46 | 0.86 | 0.91 | 0.94 | 1.06 |
| Inventory Turnover Ratio (X) | 8.58 | 8.48 | 6.77 | 4.34 | 3.97 |
| Interest Coverage Ratio (X) | -1.48 | 0.22 | 0.19 | 0.45 | 0.89 |
| Interest Coverage Ratio (Post Tax) (X) | -1.59 | 0.20 | 0.17 | 0.42 | 0.83 |
| Enterprise Value (Cr.) | 201.55 | 807.36 | 730.02 | 377.91 | 507.33 |
| EV / Net Operating Revenue (X) | 0.37 | 1.15 | 1.16 | 0.87 | 1.22 |
| EV / EBITDA (X) | -3.18 | 51.44 | 57.21 | 16.27 | 10.63 |
| MarketCap / Net Operating Revenue (X) | 0.53 | 0.37 | 0.23 | 0.43 | 0.64 |
| Price / BV (X) | 0.27 | -5.13 | -3.05 | -102.76 | 8.62 |
| Price / Net Operating Revenue (X) | 0.53 | 0.37 | 0.23 | 0.43 | 0.64 |
| EarningsYield | 1.37 | -0.20 | -0.35 | -0.14 | -0.04 |
After reviewing the key financial ratios for Hindustan Organic Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 58.33. This value is within the healthy range. It has increased from -8.05 (Mar 24) to 58.33, marking an increase of 66.38.
- For Diluted EPS (Rs.), as of Mar 25, the value is 58.33. This value is within the healthy range. It has increased from -8.05 (Mar 24) to 58.33, marking an increase of 66.38.
- For Cash EPS (Rs.), as of Mar 25, the value is 58.51. This value is within the healthy range. It has increased from -7.83 (Mar 24) to 58.51, marking an increase of 66.34.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 155.40. It has increased from -13.00 (Mar 24) to 155.40, marking an increase of 168.40.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 155.40. It has increased from -13.00 (Mar 24) to 155.40, marking an increase of 168.40.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 79.66. It has decreased from 104.64 (Mar 24) to 79.66, marking a decrease of 24.98.
- For PBDIT / Share (Rs.), as of Mar 25, the value is -9.42. This value is below the healthy minimum of 2. It has decreased from 2.33 (Mar 24) to -9.42, marking a decrease of 11.75.
- For PBIT / Share (Rs.), as of Mar 25, the value is -9.67. This value is below the healthy minimum of 0. It has decreased from 2.12 (Mar 24) to -9.67, marking a decrease of 11.79.
- For PBT / Share (Rs.), as of Mar 25, the value is 58.70. This value is within the healthy range. It has increased from -8.22 (Mar 24) to 58.70, marking an increase of 66.92.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 58.27. This value is within the healthy range. It has increased from -8.04 (Mar 24) to 58.27, marking an increase of 66.31.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 58.24. This value is within the healthy range. It has increased from -8.12 (Mar 24) to 58.24, marking an increase of 66.36.
- For PBDIT Margin (%), as of Mar 25, the value is -11.82. This value is below the healthy minimum of 10. It has decreased from 2.22 (Mar 24) to -11.82, marking a decrease of 14.04.
- For PBIT Margin (%), as of Mar 25, the value is -12.13. This value is below the healthy minimum of 10. It has decreased from 2.02 (Mar 24) to -12.13, marking a decrease of 14.15.
- For PBT Margin (%), as of Mar 25, the value is 73.68. This value is within the healthy range. It has increased from -7.85 (Mar 24) to 73.68, marking an increase of 81.53.
- For Net Profit Margin (%), as of Mar 25, the value is 73.14. This value exceeds the healthy maximum of 10. It has increased from -7.68 (Mar 24) to 73.14, marking an increase of 80.82.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 73.11. This value exceeds the healthy maximum of 20. It has increased from -7.76 (Mar 24) to 73.11, marking an increase of 80.87.
- For Return on Networth / Equity (%), as of Mar 25, the value is 37.47. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 37.47, marking an increase of 37.47.
- For Return on Capital Employeed (%), as of Mar 25, the value is -5.43. This value is below the healthy minimum of 10. It has decreased from 14.22 (Mar 24) to -5.43, marking a decrease of 19.65.
- For Return On Assets (%), as of Mar 25, the value is 25.04. This value is within the healthy range. It has increased from -3.47 (Mar 24) to 25.04, marking an increase of 28.51.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. It has increased from -0.04 (Mar 24) to 0.00, marking an increase of 0.04.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.19. This value is within the healthy range. It has increased from -16.20 (Mar 24) to 0.19, marking an increase of 16.39.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.34. It has decreased from 0.45 (Mar 24) to 0.34, marking a decrease of 0.11.
- For Current Ratio (X), as of Mar 25, the value is 3.61. This value exceeds the healthy maximum of 3. It has increased from 0.91 (Mar 24) to 3.61, marking an increase of 2.70.
- For Quick Ratio (X), as of Mar 25, the value is 3.46. This value exceeds the healthy maximum of 2. It has increased from 0.86 (Mar 24) to 3.46, marking an increase of 2.60.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 8.58. This value exceeds the healthy maximum of 8. It has increased from 8.48 (Mar 24) to 8.58, marking an increase of 0.10.
- For Interest Coverage Ratio (X), as of Mar 25, the value is -1.48. This value is below the healthy minimum of 3. It has decreased from 0.22 (Mar 24) to -1.48, marking a decrease of 1.70.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -1.59. This value is below the healthy minimum of 3. It has decreased from 0.20 (Mar 24) to -1.59, marking a decrease of 1.79.
- For Enterprise Value (Cr.), as of Mar 25, the value is 201.55. It has decreased from 807.36 (Mar 24) to 201.55, marking a decrease of 605.81.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.37. This value is below the healthy minimum of 1. It has decreased from 1.15 (Mar 24) to 0.37, marking a decrease of 0.78.
- For EV / EBITDA (X), as of Mar 25, the value is -3.18. This value is below the healthy minimum of 5. It has decreased from 51.44 (Mar 24) to -3.18, marking a decrease of 54.62.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.53. This value is below the healthy minimum of 1. It has increased from 0.37 (Mar 24) to 0.53, marking an increase of 0.16.
- For Price / BV (X), as of Mar 25, the value is 0.27. This value is below the healthy minimum of 1. It has increased from -5.13 (Mar 24) to 0.27, marking an increase of 5.40.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.53. This value is below the healthy minimum of 1. It has increased from 0.37 (Mar 24) to 0.53, marking an increase of 0.16.
- For EarningsYield, as of Mar 25, the value is 1.37. This value is below the healthy minimum of 5. It has increased from -0.20 (Mar 24) to 1.37, marking an increase of 1.57.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Hindustan Organic Chemicals Ltd:
- Net Profit Margin: 73.14%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -5.43% (Industry Average ROCE: 8.77%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 37.47% (Industry Average ROE: 12.72%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): -1.59
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 3.46
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 29.8)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.19
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 73.14%
About the Company - Qualitative Analysis
Hindustan Organic Chemicals Ltd. is a Public Limited Listed company incorporated on 12/12/1960 and has its registered office in the State of Kerala, India. Company's Corporate Identification Number(CIN) is L99999KL1960GOI082753 and registration number is 082753. Currently company belongs to the Industry of Chemicals - Organic - Benzene Based. Company's Total Operating Revenue is Rs. 535.87 Cr. and Equity Capital is Rs. 67.27 Cr. for the Year ended 31/03/2025.
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Organic - Benzene Based | Ambalamugal PO, Ernakulam Kerala 682302 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Yogendra Prasad Shukla | Chairman & M.D & CFO |
| Mr. Subodh Kumar | Non Official Independent Director |
| Mr. Vinay Kumar Sharma | Non Official Independent Director |
| Mr. Manoj Sethi | Government Nominee Director |
| Ms. Vandana | Government Nominee Director |
FAQ
What is the intrinsic value of Hindustan Organic Chemicals Ltd?
Hindustan Organic Chemicals Ltd's intrinsic value (as of 06 March 2026) is ₹961.92 which is 3160.75% higher the current market price of ₹29.50, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹198 Cr. market cap, FY2025-2026 high/low of ₹45.0/22.6, reserves of ₹953 Cr, and liabilities of ₹1,539 Cr.
What is the Market Cap of Hindustan Organic Chemicals Ltd?
The Market Cap of Hindustan Organic Chemicals Ltd is 198 Cr..
What is the current Stock Price of Hindustan Organic Chemicals Ltd as on 06 March 2026?
The current stock price of Hindustan Organic Chemicals Ltd as on 06 March 2026 is ₹29.5.
What is the High / Low of Hindustan Organic Chemicals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Hindustan Organic Chemicals Ltd stocks is ₹45.0/22.6.
What is the Stock P/E of Hindustan Organic Chemicals Ltd?
The Stock P/E of Hindustan Organic Chemicals Ltd is .
What is the Book Value of Hindustan Organic Chemicals Ltd?
The Book Value of Hindustan Organic Chemicals Ltd is 152.
What is the Dividend Yield of Hindustan Organic Chemicals Ltd?
The Dividend Yield of Hindustan Organic Chemicals Ltd is 0.00 %.
What is the ROCE of Hindustan Organic Chemicals Ltd?
The ROCE of Hindustan Organic Chemicals Ltd is 5.20 %.
What is the ROE of Hindustan Organic Chemicals Ltd?
The ROE of Hindustan Organic Chemicals Ltd is 21.6 %.
What is the Face Value of Hindustan Organic Chemicals Ltd?
The Face Value of Hindustan Organic Chemicals Ltd is 10.0.